Liangliang Dai | Drug Delivery Systems | Best Researcher Award

Prof Liangliang Dai, Northwestern Polytechnical University, China

Prof. Liangliang Dai Associate Professor & Assistant Dean, Institute of Medical Research, Northwestern Polytechnical University. With a PhD and MD in Biomedical Engineering and Biology from Chongqing University under Prof. Kaiyong Cai, Prof. Dai’s research focuses on nanomaterials, drug delivery systems, nanosystems, tumor immunotherapy, and antimetabolic therapy. He has led multiple national and provincial research projects and published in top journals like Nature Communications and Advanced Functional Materials. His innovative work bridges nanotechnology and cancer therapy, advancing biomedical science. 🔬🌿

Publication Profile

orcid

Education Background

Prof. Liangliang Dai holds a Ph.D. in Biomedical Engineering 🎓 from the Ministry of Education College of Bioengineering at Chongqing University, where he conducted advanced research under the mentorship of Prof. Kaiyong Cai. His academic journey also includes an MD in Biology 🧬 from the same institution, further solidifying his expertise in bioengineering and biomedical sciences. Guided by Prof. Cai, his studies focused on cutting-edge innovations in the field. With a strong foundation in interdisciplinary research, Prof. Dai continues to contribute to scientific advancements in biomedical engineering and biology, shaping the future of healthcare and biotechnology 🔬.

Hosted Research Project

Prof. Liangliang Dai has led several prestigious research projects 🔬, contributing significantly to biomedical engineering. He has been awarded funding from the National Natural Science Foundation of China 🏅 for multiple projects (52373157, 52003223) and has received the National Science Foundation for Distinguished Young Scholars of Shaanxi Province (S2025-JC-JQ-0228). Additionally, he has played a key role in the Key R&D Programs of Shaanxi Province (2024SF2-GJHX-26, 2022SF-012) and secured support from the Natural Science Foundation of Shaanxi Province (2019JQ-347) and the Young Talent Fund of University Association for Science and Technology (20200302) 🌍.

Research Contributions

Prof. Liangliang Dai has secured multiple prestigious research grants 🏅, including funding from the National Natural Science Foundation of China and the Key R&D Program of Shaanxi Province. His research focuses on advanced drug delivery systems 💊, tumor immunotherapy 🧬, and biomedical nanotechnology 🔬, making significant contributions to the medical research community. These competitive grants reflect his expertise and the high regard for his work in the scientific field. Through pioneering innovations, Prof. Dai continues to push the boundaries of biomedical engineering, striving for breakthroughs that enhance healthcare and therapeutic solutions globally 🌍.

Global Recognition

Prof. Liangliang Dai is a globally recognized researcher 🌍, collaborating with renowned scientists to develop innovative therapeutic strategies 🔬. His groundbreaking work in cancer therapy 🧬 and nanomaterial-based drug delivery 💊 is paving the way for more effective medical treatments. Beyond securing prestigious grants and publishing impactful research, his contributions hold practical significance in biomedical applications, transforming healthcare solutions. With a commitment to advancing science, Prof. Dai’s influence continues to grow, driving innovation and shaping the future of medicine through cutting-edge technologies and interdisciplinary collaborations 🤝.

Innovative Research

Prof. Liangliang Dai’s research is highly interdisciplinary 🔬, blending nanotechnology, immunotherapy, and bioengineering to advance medical science. His groundbreaking work on multifunctional metal-organic frameworks 🏗️, light-activatable antibiosis for infected bone repair 🦴, and tumor microenvironment modulation 🧬 showcases his pioneering role in translational medicine. By enhancing cancer treatment strategies 🎗️ and optimizing drug delivery systems 💊, his studies have a direct impact on healthcare. Through cutting-edge innovations, Prof. Dai is shaping the future of biomedical science, driving transformative solutions that improve patient outcomes and therapeutic effectiveness worldwide 🌍.

Research Focus

Liangliang Dai’s research primarily focuses on nanotechnology and biomedical engineering 🧪🔬, with a particular emphasis on nanosystems for drug delivery, tumor therapy, and environmental applications. His work explores nanoparticles, metal-organic frameworks (MOFs), and photo-responsive materials to develop advanced cancer treatments 🎗️, chemodynamic therapy ⚛️, immune modulation 🛡️, and antimicrobial strategies 🦠. Dai also investigates water purification 💧 and biofilm control to tackle antibiotic resistance. His research bridges materials science 🏗️ and biomedicine to create multifunctional therapeutic nanosystems, advancing precision medicine 🧬 and environmental health 🌍.

Publication Top Notes

Nanosilver-Induced Pseudo Cuproptosis of Potentially Pathogenic Bacteria during the Storage of Ozone-Treated Wastewater

MMP-2/GSH-responsive nanobomb for tumor chemo-immunotherapy with hierarchical delivery and TAMs re-education by regulating hbegf-activated ERK/MAPK signal pathway

An Adjuvant Micelle-Based Multifunctional Nanosystem for Tumor Immunotherapy by Remodeling Three Types of Immunosuppressive Cells.

Multifunctional Fe-based coordination polymer nano-bomb modified with β-lapachone and CaO2 for targeted tumor dual chemodynamic therapy with enhanced ferroptosis and H2O2 self-supply.

A Photo‐Therapeutic Nanocomposite with Bio‐Responsive Oxygen Self‐Supplying Combats Biofilm Infections and Inflammation from Drug‐Resistant Bacteria

Detachable MOF-Based Core/Shell Nanoreactor for Cancer Dual-Starvation Therapy With Reversing Glucose and Glutamine Metabolisms.

Engineered drug delivery nanosystems for tumor microenvironment normalization therapy

Cascade amplification of tumor chemodynamic therapy and starvation with re-educated TAMs via Fe-MOF based functional nanosystem

Editorial: Advances in the development of functional biomaterial nanosystem in tumor therapy and tissue regeneration.

Dipanjan Karati | Drug Discovery and Development | Best Researcher Award

Dr Dipanjan Karati, Techno India University, West Bengal, India

Dr. Dipanjan Karati is an Assistant Professor at Techno India University, West Bengal, with expertise in pharmaceutical chemistry. He holds a M. Pharm (2021) from Bharati Vidyapeeth University and a B. Pharm (2019) from MAKAUT, both with distinction. His research focuses on neurodegenerative diseases and antimicrobial agents, with several publications in prestigious journals. Dr. Karati has actively participated in numerous seminars, webinars, and workshops. He is a GPAT 2019 qualifier and has industrial training at Glenmark Pharmaceuticals. He is passionate about academics and research in the field of drug development. 📚💊🧠🔬👨‍🔬

Academic Excellence

Dr. Dipanjan Karati is a highly qualified pharmaceutical professional with a strong academic background. He completed his M. Pharm in Pharmaceutical Chemistry from Poona College of Pharmacy, Bharati Vidyapeeth University, Pune, in 2021, securing a first-class distinction with an 8.09 CGPA. Prior to that, he earned his B Pharm from NSHM Knowledge Campus, Kolkata, in 2019, with an outstanding 80.2% (1st class with distinction). Dr. Karati completed his HSC in 2013 with 81.2% and SSC in 2011 with 78.125% from Garh Bhawanipur RP Institution, Howrah. His consistent academic performance highlights his dedication to the pharmaceutical field. 📚💊🎓

Research Project

Dr. Dipanjan Karati’s research focuses on the “In Silico Design, Synthesis, and Evaluation of Novel Schiff Base Congeners as Neurodegenerative and Antimicrobial Agents.” His objective is to design and synthesize innovative pyrimidine derivatives containing a nitrile group and substituted Schiff bases with azomethine groups. These compounds are being explored for their potential in treating neurodegenerative diseases and exhibiting antimicrobial properties. Dr. Karati’s work combines advanced computational techniques and experimental synthesis to develop effective therapeutic agents, aiming to contribute significantly to the fields of neurodegenerative diseases and antimicrobial resistance. 🔬🧠💊🦠💡

Experience

Dr. Dipanjan Karati has an impressive academic and professional background in the pharmaceutical field. He completed his Industrial Training at Glenmark Pharmaceutical Limited from January 9th to 23rd, 2018, gaining valuable industry experience. He served as an Assistant Professor at Gitanjali College of Pharmacy in Lohapur, Birbhum, for one year, contributing to the academic development of students. Currently, Dr. Karati holds the position of Assistant Professor at the School of Pharmacy, TIU, since September 2022, continuing his dedication to education and research. 📚💊👨‍🏫

Achievements and Awards

Dr. Dipanjan Karati achieved a significant milestone by qualifying for the All India Graduate Pharmacy Aptitude Test (GPAT) in 2019, showcasing his dedication and expertise in the field of pharmacy. 🏆📚 This prestigious achievement highlights his academic excellence and potential for contributing to pharmaceutical sciences. 🌟💊 With his strong foundation and passion for research, Dr. Karati is committed to advancing innovations in pharmacy and healthcare. 🚀🔬 His GPAT qualification is a testament to his hard work and determination, inspiring others in the field to strive for academic and professional success. 🌱🎓

Research Focus

Dr. Dipanjan Karati’s research focuses on medicinal chemistry, pharmacognosy, and drug discovery. His studies emphasize exploring bioactive compounds from plants 🌱, such as Ficus racemosa and Zingiber officinale, for their pharmacological properties including anti-inflammatory, anticancer, and antimicrobial activities 🧪🩺. He investigates synthetic scaffolds like pyrazoles and benzimidazoles for designing innovative therapies targeting diseases such as cancer, malaria, and infections 🎯🧬. Dr. Karati also explores bio-responsive polymers for targeted drug delivery and examines natural products like Cordyceps sinensis for therapeutic potential 🍄🔬. His work bridges natural products and modern medicinal approaches, advancing personalized treatments 🌟📖.